Pregnancy and Heart Disease. Shilpa Kshatriya, MD, FACC Heartland Cardiology, PA
|
|
- Janice McBride
- 5 years ago
- Views:
Transcription
1 Pregnancy and Heart Disease Shilpa Kshatriya, MD, FACC Heartland Cardiology, PA
2 Pregnancy and the Heart 2 % of pregnancies involve maternal CV disease CV disease does not preclude pregnancy but poses risk to the MOTHER and FETUS
3 Hemodynamic Changes > 40% increase in blood volume Decrease in SVR and PVR Increase in HR 30 % increase C.O Little change in BP USUALLY WELL TOLERATED
4 Hemodynamic Changes Labor and Delivery C.O increases by 60 to 80% (HR and BP changes) Volume Changes Increase blood volume with uterine contraction Increased Venous Return Volume loss during delivery
5 Mode of Delivery Vaginal-preferable in most Facilitate 2 nd stage C-section OB reasons Warfarin anticoagulation Rare CV reasons-severe PHTN, severe obstructive lesions, unstable aorta
6 Advise Against Pregnancy Severe pulmonary arterial hypertension Severe obstructive lesions- AS, MS, PS, HCM, Coarct Ventricular dysfunction- Class III or IV CHF, EF < 40%, Prior PPCM Dilated or unstable aorta-marfan with aorta > 40 to 45mm Severe cyanosis
7 Preconception Evaluation
8 Prepregnancy Risk Assessment Risk of pregnancy depends on specific heart disease and clinical status of the patient CARPREG ZAHARA WHO Classification
9
10
11
12
13
14
15
16
17 WHO Risk and Prenatal Care Class I -- one or two CV visits Class II CV f/u every trimester Class III monthly/bimonthly CV f/u Class IV pregnancy is contraindicated Consider termination If pregnancy continues monthly or bimonthly
18 Tetralogy of Fallot One of the most common forms of cyanotic CHD and most adults have had previous repair. In unrepaired TOF, including those with previous palliative shunts, pregnancy is not advised because of poor maternal and fetal outcomes. After surgical repair, pregnancy is generally well tolerated in those women who have good functional capacity and no hemodynamically significant residual lesions. A significant percentage of patients develop pulmonary regurgitation after repair of TOF, which may lead to RV enlargement and dysfunction, decreased exercise tolerance, and arrhythmias.
19 TOF
20 Pulmonary Hypertension 4% to 10% of all patients with CHD result of long-term left to right shunting and excessive pulmonary circulation. In some patients with large left to right shunts at birth, the pulmonary pressure equals the systemic pressures, resulting in shunt reversal and cyanosis (known as the Eisenmenger syndrome)
21 Pulmonary HTN Pregnancy in mothers with Eisenmenger syndrome is contraindicated because of high maternal and fetal mortality.---up to 50% maternal mortality. Death occurs most commonly in the third trimester or first few weeks after successful delivery, so that continued monitoring in the postpartum period is required
22 Left to Right Shunts Uncomplicated ASD/VSD/PDA without pulm. HTN are well tolerated in pregnancy Large defects a/w pulm. HTN are associated with increased risk---arrhythmias, ventricular dysfunction, worsening pulm. HTN
23 Pregnancy in Marfan Preexisting medial changes Changes with pregnancy Physiologic, hormonal Unpredictable maternal risk Dissection, IE, CHF Fetal- 50% inheritance (AD) Oxytocin-implicated in dissection
24 CV history, FH, meds Aortic Imaging Aorta > 45mm------no pregnancy Aorta 40 mm-----reasonable Aorta 40 to 45mm----individualize
25 Pregnancy In Aortic Disorders During pregnancy---beta blocker, Aortic imaging, fetal echo Peripartum ---facilitated vaginal delivery, C- section for Ao > 40mm or increasing size, IE prophylaxis Postpartum-dissection risk persists
26
27 Supraventricular Tachycardia
28 SVT Acute treatment- iv adenosine Hemodynamic instability- DC cardioversion Maintenance beta blocker, calcium channel blocker, sotalol, flecainide Ablation
29 Ventricular Tachycardia Underlying heart disease PPCM Long QT- beta blocker ICD recommended prior to pregnancy Idiopathic VT (healthy patients)- beta blocker, verapamil, sotalol, flecainide, propafenone Unstable VT-DC cardioversion, iv amiodarone Catheter ablation-refractory cases
30 Hypertrophic Cardiomyopathy Most common genetic cardiac disease Risk higher if symptomatic prior to pregnancy Heart failure symptoms Arrhythmias- afib, PVCs, NSVT, VT Risk in pregnancy increased if high outflow tract gradient Beta blockers Low risk cases-vaginal delivery Epidural-vasodilation and hypotension caution in severe LVOT obstruction
31
32 Acute MI in Pregnancy 3 to 6 per 100,000 deliveries Mortality 7% Age > 35 years, multiparous, non-hispanic white or African American Risk factors- chronic HTN, DM, older age, eclampsia/preeclampsia, smoking Exclude SCAD (delivery, early postpartum) and aortic dissection
33 Acute MI in Pregnancy PCI- bare metal stent, CABG-limited date (drug eluting stents not recommended) Thrombolysis if cath/pci not available Heparin/aspirin/beta blocker/nitrates Nitrates excreted in breast milk- fetal methemoglobinemia Plavix- safety not established during pregnancy Statins-possibly teratogenic
34 Valvular Heart Disease AORTIC STENOSIS Main cause in reproductive age bicuspid aortic valve Cardiac morbidity dependent on symptoms and severity Heart failure occurs in 10% severe AS Arrhythmias- 3 to 25% Risk of aortic dilatation/dissection
35
36 Aortic Stenosis Interventions during pregnancy- valvuloplasty if minimal aortic regurgitation. Valve replacement after prompt C-section Mode of delivery-c-section for severe AS
37 Mitral Stenosis Moderate or severe MS poorly tolerated during pregnancy CHF ( MVA < 1.5cm2) Afib can occur----increases risk of pulm. Edema Mgt- beta blockers, diuretics, anticoagulation if in afib Percutaneous mitral commissurotomy after 20 weeks
38 VHD in Pregnancy Tissue Prosthesis Increased degeneration in young Reoperation risk Possible accelerated degeneration in pregnancy
39 VHD in Pregnancy Mechanical Prosthesis Anticoagulation Increased thrombosis risk
40 Anticoagulation in Pregnancy Hematologic changes clotting factor concentration platelet adhesiveness fibrinolysis and protein S activity risk thrombosis and embolism
41 Warfarin in Pregnancy Low molecular weight---crosses placenta Fetal anticoagulation effect (decreased vit K dependent factors in fetal liver) Increased risk fetal loss, prematurity, stillbirth, fetal IC hemorrhage, retroplacental hemorrhage Embryopathy risk---exposure 6 to 12 weeks Incidence 4 to 10% Dose related
42 Prosthetic Valves and Pregnancy Fetal Complications Warfarin 5mg 5/33 (15%) No embryopathy Warfarin 5mg 22/25 (88%) 9% embryopathy Vitale N et al, JACC 1999
43
44
45 Anticoagulation in Pregnancy Low dose Aspirin - Safe---antithrombotic effect not proven - Used in pt with shunts, cyanosis, bioprosthesis - Possible incidence in preeclampsia Thrombolytic therapy -Emergency use only NOAC -No safety data
46 Pregnancy and the Heart CVD 1 to 2 % pregnancies Congenital heart disease most common cause Does not preclude pregnancy Increased risk to mother and fetus Individual assessment---preferably prior to conception
Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials
Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Pregnancy and Congenital Heart Disease Case Review Heidi M. Connolly, M.D. Professor of Medicine Chair for Education
More informationPregnancy and Heart Disease
Pregnancy and Heart Disease Heidi M. Connolly, MD No disclosures 2011 MFMER 3138928-1 Regitz-Zagrosek V, Lundqvist C, Borghi C, et al. Pregnancy and the Heart 2% of pregnancies involve maternal CV disease
More informationCongenital Heart Disease Patient and Pregnancy
Congenital Heart Disease Patient and Pregnancy Gurur Biliciler-Denktas, M.D. Assistant Professor Division of Pediatric Cardiology, Department of Pediatrics The University of Texas Health Science Center
More informationMaternal Cardiac Disease In Pregnancy. August 25, 2017 PREGNANCY ECHO CONFERENCE
Maternal Cardiac Disease In Pregnancy August 25, 2017 PREGNANCY ECHO CONFERENCE Maternal Physiology Cardiac Output = HR x SV Non-pregnant: 4.5 L/min Pregnant: 6.0 L/min Increase most acute in first 10
More informationClinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!
Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Abha'Khandelwal,'MD,'MS' 'Stanford'University'School'of'Medicine'
More informationPregnancy and Cardiovascular Disease
Pregnancy and Cardiovascular Disease Cindy M. Martin, M.D. Co-Director, Adult Congenital and Cardiovascular Genetics Center No Disclosures Objectives Discuss the hemodynamic changes during pregnancy Define
More informationValve Disease in the Pregnant Patient
Valve Disease in the Pregnant Patient Julie B. Damp, MD December 6, 2012 VanderbiltHeart.com If single, do not allow marriage. If fertile, do not allow pregnancy. If pregnant, do not allow delivery. If
More informationESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy
ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy Task force on the management of CVD during pregnancy of the ESC Chair: Vera Regitz-Zagrosek, Charite, Berlin None DECLARATION
More informationMore History. Organization. Maternal Cardiac Disease: a historical perspective. The Parturient with Cardiac Disease 9/21/2012
The Parturient with Cardiac Disease Pamela Flood M.D. Professor of Anesthesia and Perioperative Care Obstetrics, Gynecology and Reproductive Sciences University of California, San Francisco Maternal Cardiac
More informationΈγκυος και συγγενής καρδιοπάθεια: Τι πρέπει να γνωρίζει ο Καρδιολόγος Ενηλίκων
Έγκυος και συγγενής καρδιοπάθεια: Τι πρέπει να γνωρίζει ο Καρδιολόγος Ενηλίκων Αντώνιος Π. Βλάχος Αναπληρωτής Καθηγητής Παιδοκαρδιολογίας Πανεπιστήμιο Ιωαννίνων No conflict of interest Pregnancy and CHD
More informationPREGNANCY AND CONGENITAL HEART DISEASE
PREGNANCY AND CONGENITAL HEART DISEASE SIDDHARTH JADHAV M.D. Assistant Professor of Radiology E.B. Singleton Department of Pediatric Radiology Texas Children's Hospital COMMERCIAL DISCLOSURE - None Objectives
More informationPregnancy and Heart Disease. Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital
Pregnancy and Heart Disease Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital Pregnancy is not a state Hemodynamic changes During pregnancy Estrogens 1. Renin 2.
More informationSESSION D5. The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION D5 Session Description: The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM
More informationCritical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials
Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Pregnancy and Congenital Heart Disease Heidi M. Connolly, M.D. Professor of Medicine Chair for Education Division
More informationPregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016
1 Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 DISCLOSURES I have no disclosures relevant to today s talk 2 Cardiovascular Effects of Pregnancy Anatomic Ventricular muscle mass increases
More informationCardiac Disease in Pregnancy
Cardiac Disease in Pregnancy DATE: SEPTEMBER 11, 2016 PRESENTED BY: ABIGAIL KHAN, MD Outline Scope of the problem Physiology of pregnancy Cardiac risk in pregnancy Pregnancy management Contraception 1
More informationPregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia
Pregnancy, Heart Disease and Imaging Sangeeta Shah, MD, FASE, FACC Associate Professor, Ochsner Clinical School of Medicine Advanced CV Imaging and Adult Congenital Heart Disease New Orleans, LA Hemodynamics
More informationOutline. Maternal Congenital Heart Disease in Pregnancy. Maternal congenital heart disease. Cardiovascular disease in pregnancy 10/18/2017
I have no disclosures or conflicts of interest to report. Maternal Congenital Heart Disease in Pregnancy Jennifer A. Jolley, MD Associate Clinical Professor University of California, Irvine Department
More informationΚαρδιοπάθειες και κύηση. Υπάρχουν ενδείξεις διακοπής; Λαζαρίδου Φωτεινή, ΕΒ Καρδιολόγος Νοσοκομείο «Αγ Παύλος», Θεσσαλονίκη
Καρδιοπάθειες και κύηση. Υπάρχουν ενδείξεις διακοπής; Λαζαρίδου Φωτεινή, ΕΒ Καρδιολόγος Νοσοκομείο «Αγ Παύλος», Θεσσαλονίκη ~ 3% of women 18 44 years of age have cardiac disease ~ 1% of pregnancies are
More informationEVALUATION OF PREGNANT PATIENTS WITH HEART DISEASE. Karen Stout, MD University of Washington Seattle Children s Seattle, WA
EVALUATION OF PREGNANT PATIENTS WITH HEART DISEASE Karen Stout, MD University of Washington Seattle Children s Seattle, WA CASE PRESENTATION 24 year old woman with aortic regurgitation referred for evaluation
More informationDysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics
Dysrhythmias CYDNEY STEWART MD, FACC NOVEMBER 3, 2017 Disclosures None 3 reasons to evaluate and treat dysrhythmias Eliminate symptoms and improve hemodynamics Prevent imminent death/hemodynamic compromise
More informationPregnancy in Marfan Syndrome and Bicuspid Aortic Valve Related Aortopathy
Pregnancy in Marfan Syndrome and Bicuspid Aortic Valve Related Aortopathy Heidi M. Connolly, MD Cardiac Problems in Pregnancy Venice Italy, February 2014 No Disclosures 2012 MFMER slide-1 Regitz-Zagrosek
More informationMaternal Cardiac Disease Diagnosis and Management
Maternal Cardiac Disease Diagnosis and Management Dr. Şevki ÇELEN ZTB Maternity and Teaching Hospital Department of Perinatology Heart diseases in pregnancy Today, 0.2-4% of all pregnancies are accompanied
More informationI have nothing to disclose.
I have nothing to disclose. Antiarrhythmic Therapy in Pregnancy Prof. Ali Oto,MD,FESC,FACC,FHRS Department of Cardiology Hacettepe University,Faculty of Medicine Ankara Arrhythmias in pregnancy An increased
More informationRF & RHD Workshop 22 nd March MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY. Dr Dorothy Radford
RF & RHD Workshop 22 nd March 2016 MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY Dr Dorothy Radford PREGNANCY PHYSIOLOGY Increased cardiac output 30%-50% Increased blood volume 30%-50% Increased heart
More informationCardiac disease in pre pr gnancy
IN THE NAME OF GOD Cardiac disease in pregn nancy MITRAL STENOSIS 33 y/o G3L2(2c/s) GA 34 + 5 CC: LP & dyspnea PMHx: MS sinse 4 yrs ago due to Rheumatism PSHx: 2c/s DHx: metoral 50 mg q6h/ ASA/ Enoxaparin
More informationSusan P. D Anna MSN, APRN BC February 14, 2019
Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with
More information7. Echocardiography Appropriate Use Criteria (by Indication)
Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions
More informationMiscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease. Pregnancy and Cardiovascular Disease MCQ
Miscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease Maan Jokhadar, MD, FACC Emory Center for Advanced Heart Failure Therapy Emory Adult Congenital Heart Center Pregnancy
More informationCandice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada
PVR Following Repair of TOF Now? When? Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada Late Complications after TOF repair Repair will be necessary
More informationManagement of Heart Failure and Cardiomyopathies in Pregnancy
Management of Heart Failure and Cardiomyopathies in Pregnancy Professor Sanjay Sharma Disclosures: None Epidemiology of Cardiac Disease In Pregnancy Cardiovascular disease in pregnancy is increasing in
More informationHow pregnancy impacts adult cyanotic congenital heart disease
How pregnancy impacts adult cyanotic congenital heart disease Magalie Ladouceur Adult Congenital Heart Disease Unit, Hôpital Européen Georges Pompidou, Centre de reference des Malformations Cardiaques
More informationHeart disease complicating pregnancy management strategies
www.slcog.lk/sljog LEADING ARTICLE Heart disease complicating pregnancy management strategies Priyadharshan P¹ Introduction Heart disease is the third most common cause of maternal death and the leading
More informationUC SF DISCLOSURES MANAGEMENT OF MATERNAL CONGENITAL HEART DISEASE OBJECTIVES. No financial disclosures CARDIOVASCULAR CHANGES ANTEPARTUM 6/10/2011
DISCLOSURES MANAGEMENT OF MATERNAL CONGENITAL HEART DISEASE No financial disclosures UC SF Lena H. Kim, MD AIM CONFERENCE June 10, 2011 spicecomments.com OBJECTIVES Physiologic cardiovascular changes of
More informationWhen Should I Order a Stress Test or an Echocardiogram
When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular
More informationDetailed Order Request Checklists for Cardiology
Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018
More informationCatherine Nelson-Piercy. Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK
Cardiac Disease and Pregnancy Catherine Nelson-Piercy Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK Physiological changes in pregnancy Cardiac Output (CO) increases by 40% Further
More informationCardiovascular disease complicates 1% to 3% of all
Pregnancy Complicated by Valvular Heart Disease: An Update Michael Nanna, MD; Kathleen Stergiopoulos, MD, PhD, FASE, FACC, FAHA Cardiovascular disease complicates 1% to 3% of all pregnancies and is responsible
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationASE 2011 Appropriate Use Criteria for Echocardiography
ASE 2011 Appropriate Use Criteria for Echocardiography Table 1. TTE for General Evaluation of Cardiac Structure and Function 1 2 Suspected Cardiac Etiology General With TTE Symptoms or conditions potentially
More informationUptofate Study Summary
CONGENITAL HEART DISEASE Uptofate Study Summary Acyanotic Atrial septal defect Ventricular septal defect Patent foramen ovale Patent ductus arteriosus Aortic coartation Pulmonary stenosis Cyanotic Tetralogy
More informationSurgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital
Surgical Management of TOF in Adults Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital Tetralogy of Fallot (TOF) in Adults Most common cyanotic congenital heart
More informationIntroduction to Fetal Medicine. Lloyd R. Feit M.D. Associate Professor of Pediatrics Warren Alpert Medical School Brown University
Associate Professor of Pediatrics Warren Alpert Medical School Brown University Fetal Cardiology Important in evaluation of high risk pregnancies. Information obtainable in > 95% of patients attempted.
More informationAdult Echocardiography Examination Content Outline
Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACHD. See Adult congenital heart disease (ACHD) Adult congenital heart disease (ACHD), 503 512 across life span prevalence of, 504 506
More informationClinical Indications for Echocardiography
Clinical Indications for Echocardiography Echocardiography is widely utilised and potential applications are increasing with advances in technology. The aim of this document is two-fold: 1) To define clinical
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,
More informationPregnancy and the cardiovascular system
International Journal of Cardiology 98 (2005) 179 189 Review Pregnancy and the cardiovascular system www.elsevier.com/locate/ijcard Amr E. Abbas a, *, Steven J. Lester a, Heidi Connolly b a Division of
More informationReview Article Heart Disease and Pregnancy
Hellenic J Cardiol 47: 275-291, 2006 Review Article Heart Disease and Pregnancy AIKATERINI CHAMAIDI, MICHAEL A. GATZOULIS Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton
More informationEffect of maternal heart disease on pregnancy outcomes
Expert Review of Obstetrics & Gynecology ISSN: 1747-4108 (Print) 1747-4116 (Online) Journal homepage: http://www.tandfonline.com/loi/ierb20 Effect of maternal heart disease on pregnancy outcomes Emily
More informationImaging Cardiovascular Disease in Pregnancy
Imaging Cardiovascular Disease in Pregnancy Karen Ordovas MD, MAS Associate Professor of Radiology and Medicine Director of Cardiac Imaging University of California San Francisco Cardiac MRI during pregnancy
More informationAnaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO)
Anaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO) Dr. Siân Jaggar Consultant Anaesthetist Royal Brompton Hospital London UK Congenital Cardiac Services
More informationAdult with Cyanotic Congenital Heat Disease
Adult with Cyanotic Congenital Heat Disease Savitri Srivastava Director, Pediatric & Congenital Heart Disease Fortis Escorts Heart Institute Okhla Road, New Delhi Cyanotic Adult WCC & IVUS 2015 Adult Cyanotic
More informationHeart Failure treatment during pregnancy
Heart Failure treatment during pregnancy Angeles Alonso García Hospital Universitario Puerta de Hierro. Majadahonda. Madrid. Spain European Society of Cardiology. Stockholm. 29 August 2010 Starting Point
More informationSudden cardiac death: Primary and secondary prevention
Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)
More informationCardiovascular Recommendation Tables
Cardiovascular Recommendation Tables Current as of: February, 2009 The first publication of the Cardiovascular Recommendation Tables occurred in the October 2002, Cardiovascular Advisory Panel Guidelines
More informationAtrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018
Atrial Fibrillation and the NOAC s John Raymond MS, PA-C, MHP February 10, 2018 Pathogenesis EPIDEMIOLOGY Arrhythmia-related hospitalisations in the US Ventricular fibrillation 2% Atrial fibrillation 34%
More informationPeripartum Cardiomyopathy. Lavanya Rai Manipal
Peripartum Cardiomyopathy Lavanya Rai Manipal Definition - PPCM - Dilated cardiomyopathy of unknown cause resulting in cardiac failure that occurs in the peripartum period in women without any preexisting
More informationFocused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig.
ACC/AH HA 2006 Guidel nic severe AI (Fig. 4). ned by age, ay also be helpful nd echo. For AI, ollow up may be or MRI rather than mension; SD, end lines for Manag gement of Patie Upd ents With Valvul date
More informationValvular Heart Disease Mitral Stenosis
Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema
More informationRate of CHD at birth: 4~12/1,000
Risk assessment and management for the pregnant ACHD woman Suk-Joo Choi Department of Obstetrics and Gynecology Samsung Medical Center Sungkyunkwan k University i School of Medicine i Cardiac diseases
More informationRecommended Evaluation Data Excerpt from NVIC 04-08
Recommended Evaluation Data Excerpt from NVIC 04-08 Purpose: This document is an excerpt from the Medical and Physical Evaluations Guidelines for Merchant Mariner Credentials, contained in enclosure 3
More informationImages in Cardiovascular Medicine
Images in Cardiovascular Medicine Management of Severe Mitral Stenosis During Pregnancy Rebecca S. Norrad, MBBS; Omid Salehian, MSc, MD, FRCPC, FACC, FAHA A 37-year-old woman originally from Iraq was referred
More informationMULTIDISCIPLINARY APPROACH TO PERIPARTUM CARE
MULTIDISCIPLINARY APPROACH TO PERIPARTUM CARE MARY M. CANOBBIO, RN, MN, FAAN, FAHA AHMANSON/UCLA ACHDCENTER UCLA SCHOOL OF NURSING LOS ANGELES, CALIFORNIA GROWING POPULATION OF ADULTS WITH CONGENTITAL
More informationCASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG
CASE DISCUSSION Dr JAYASREE VEERABOINA 2nd yr PG MS OBG Normal Cardiovascular changes in Pregnancy CARDIAC OUTPUT 5 th wk -- starts 12 wks -- 30-35% 30-32 wks -- 40% During labour -- 50% After delivery
More informationCardiology New Horizons in Cardiovascular Disease Management. Christopher Wulff, MD Cardiovascular Consultants Medical Group
New Horizons in Cardiovascular Disease Management Christopher Wulff, MD Cardiovascular Consultants Medical Group Structural Heart Valvular TAVR MitraClip Congenital Pharmacology Heart Failure Management
More informationComprehensive Cardiology: Matters of the Heart Class III SARAH BEANLANDS RN BSCN MSC
Comprehensive Cardiology: Matters of the Heart Class III SARAH BEANLANDS RN BSCN MSC Overview ACS continued Heart Failure Valvular Disorders and Endocarditis Diagnosis Nuclear stress test- stable angina
More informationThe dos and don ts των νέων Κατευθυντηρίων Οδηγιών της Ευρωπαϊκής Καρδιολογικής Εταιρείας Για την καρδιαγγειακή νόσο στην εγκυμοσύνη
The dos and don ts των νέων Κατευθυντηρίων Οδηγιών της Ευρωπαϊκής Καρδιολογικής Εταιρείας Για την καρδιαγγειακή νόσο στην εγκυμοσύνη Θωμάς Κ. Μακρής, MD FA, FES Συντονιστής Διευθυντής Καρδιολογικού Τμήματος
More informationCARDIAC DISEASE IN PREGNANCY: TUTORIAL 2 TUTORIAL OF THE WEEK TH NOVEMBER 2008
CARDIAC DISEASE IN PREGNANCY: TUTORIAL 2 TUTORIAL OF THE WEEK 118 10 TH NOVEMBER 2008 Dr. Abbi Walker, Christchurch Hospital, New Zealand Dr. Matt Rucklidge, Royal Devon & Exeter Hospital, UK mattrucklidge@yahoo.co.uk
More informationIntroduction. Pediatric Cardiology. General Appearance. Tools of Assessment. Auscultation. Vital Signs
Introduction Pediatric Cardiology An introduction to the pediatric patient with heart disease: M-III Lecture Douglas R. Allen, M.D. Assistant Professor and Director of Community Pediatric Cardiology at
More informationCardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology
Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations
More informationHeart Failure. Dr. William Vosik. January, 2012
Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acid base balance pregnancy-related changes to, 640 Acquired heart disease, 731 Acute fatty liver of pregnancy (AFLP), 618 Acute kidney
More informationPERIPARTUM CARDIOMYOPATHY
PERIPARTUM CARDIOMYOPATHY Dr.T.Venkatachalam. Professor of Anaesthesiology Madras Medical College, Chennai Peripartum cardiomyopathy is defined as the onset of acute heart failure without demonstrable
More informationATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION
ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION Frederick Schaller, DO, MACOI,FACP Adjunct Clinical Professor Touro University Nevada DISCLOSURES I have no financial relationships
More informationAdult Congenital Heart Disease: A Growing Problem. Dr. Gary Webb Cincinnati Children s Hospital Heart Institute
Adult Congenital Heart Disease: A Growing Problem Dr. Gary Webb Cincinnati Children s Hospital Heart Institute ACHD Resources in Ohio ACHAHEART.ORG Situations When We Might Help When you don t know a
More informationSteel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015
Steel vs Alcohol Or Neither Management of Hypertrophic Cardiomyopathy Josh Doll, MD January 24, 2015 47yo Male, Mr. L Severe progressive dyspnea on exertion and weight gain Previous avid Cross-Fit participant
More informationPregnant woman with congenital heart disease. A. Pijuan Domènech (U. de C. Congènites de l Adult) ACOR, Hospital Vall d Hebron Barcelona, Spain
Pregnant woman with congenital heart disease A. Pijuan Domènech (U. de C. Congènites de l Adult) ACOR, Hospital Vall d Hebron Barcelona, Spain Pregnant women with congenital heart disease Maternal mortality/10e6
More informationPregnancy and cyanotic congenital heart disease. A. Pijuan Domènech (U. de C. Congènites de l Adult) Hospital Vall d Hebron Barcelona, Spain
Pregnancy and cyanotic congenital heart disease A. Pijuan Domènech (U. de C. Congènites de l Adult) Hospital Vall d Hebron Barcelona, Spain I have nothing to disclose. Pregnancy and cyanotic congenital
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More informationAppropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating)
Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating) Table 1: Appropriate indications (median score 7-9) Indication
More informationADULT CONGENITAL HEART DISEASE AN UPDATE FOR CARDIOLOGISTS AND PRIMARY CARE PHYSICIANS
ADULT CONGENITAL HEART DISEASE AN UPDATE FOR CARDIOLOGISTS AND PRIMARY CARE PHYSICIANS V.S. Mahadevan, MD, F.R.C.P. Director, Structural and Adult congenital Interventional Cardiology Program William W
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationWhen to implant an ICD in systemic right ventricle?
When to implant an ICD in systemic right ventricle? Département de rythmologie et de stimulation cardiaque Nicolas Combes n.combes@clinique-pasteur.com Pôle de cardiologie pédiatrique et congénitale Risk
More informationAerobic Exercise Screening Stratification Tool
Aerobic Screening Stratification Tool Disclaimer: The Aerobics Screening Stratification Tool is a working document currently used within the Stroke Rehabilitation Service of Toronto Rehabilitation Institute
More informationValvular Heart Disease. Dr. HANAN ALBACKR
Valvular Heart Disease Dr. HANAN ALBACKR Valvular Heart Disease Format for this lecture IMPORTANT CLINICAL INFO know for boards, tests and clinical practice Spectrum of VHD Aortic Valve Mitral Valve Tricuspid
More informationValvular Heart Disease
Valvular Heart Disease B K Singh, MD, FACC Disclosures: None 1 CARDIAC CYCLE S2 S2=A2P2 S1=M1T1 S4 S1 S3 2 JVP Carotid S1 Slitting of S2 S3 S4 Ejection click Opening snap Dynamic Auscultation What is the
More informationCongenital Heart Disease
Congenital Heart Disease Mohammed Alghamdi, MD, FRCPC, FAAP, FACC Associate Professor and Consultant Pediatric Cardiology, Cardiac Science King Fahad Cardiac Centre King Saud University INTRODUCTION CHD
More informationCardiac Interventions in Pregnancy
Cardiac Interventions in Pregnancy Introduction 0.2% 4% of all pregnancies are complicated by cardiovascular diseases: At present congenital heart disease in developed countries and rheumatic valvular
More informationAdults with Congenital Heart Disease. Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP
Adults with Congenital Heart Disease Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP Outline History of CHD Statistics Specific lesions (TOF, TGA, Single ventricle) Erythrocytosis Pregnancy History
More informationHow does taking warfarin affect Exercise Regimen? By Dr.*~LoOKTaO ~* ÿ
How does taking warfarin affect Exercise Regimen? By Dr.*~LoOKTaO ~* ÿ no consistent recommendations available regarding safety of certain sports & exercise any sports w/ high risk of trauma, especially
More informationHeart Disease in Pregnancy
Chart 2-1. Heart Disease in Pregnancy Loryn S. Feinberg, MD, FACC MMS 8 th Annual Women s Cardiac Health Conference Friday, February 1, 2013 No disclosures 1 Chart 2-17. Objectives Understand the hemodynamic
More informationInterventions in Adult Congenital Heart Disease: Role of CV Imaging. Associate Professor. ACHD mortality. Pillutla. Am Heart J 2009;158:874-9
Interventions in Adult Congenital Heart Disease: Role of CV Imaging Sangeeta Shah MD, FACC, FASE Associate Professor ACHD mortality Pillutla. Am Heart J 2009;158:874-9 Adult Congenital Heart Disease Heterogenity
More informationExpert consensus document on management of cardiovascular diseases during pregnancy
European Heart Journal (2003) 24, 761 781 Guidelines Expert consensus document on management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases During
More informationECHOCARDIOGRAPHIC APPROACH TO CONGENITAL HEART DISEASE: THE UNOPERATED ADULT
ECHOCARDIOGRAPHIC APPROACH TO CONGENITAL HEART DISEASE: THE UNOPERATED ADULT Karen Stout, MD, FACC Divisions of Cardiology University of Washington Medical Center Seattle Children s Hospital NO DISCLOSURES
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More informationWhat to do when a heart failure patient becomes pregnant
BSH Heart Failure Day for Revalidation and Training 2017 What to do when a heart failure patient becomes pregnant Dr Diane Barker Consultant Cardiologist Royal Stoke Hospital Conflicts of interest - sponsorship,
More informationValvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong
Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong Management of valvular heart disease Accurate diagnosis and disease severity Prevention and treatment
More informationHow to manage the pregnant woman with heart disease
How to manage the pregnant woman with heart disease Dr Fiona Walker, The Heart Hospital,UCLH, London Dr Sara Thorne, University Hospital Birmingham Dr Cathy Head, The Heart Hospital, UCLH, London Dr Kate
More informationPeripartum management of Rheumatic Heart Disease
Peripartum management of Rheumatic Heart Disease Dr James Sartain Director of Anaesthesia & Perioperative Medicine Cairns & Hinterland Hospital & Health Service Talk outline Why (still) talk about RHD
More information